Citadel Advisors - ORTHO CLINICAL DIAGNOSTICS H ownership

ORTHO CLINICAL DIAGNOSTICS H's ticker is OCDX and the CUSIP is G6829J107. A total of 174 filers reported holding ORTHO CLINICAL DIAGNOSTICS H in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ORTHO CLINICAL DIAGNOSTICS H
ValueSharesWeighting
Q1 2022$4,841,000
+35.4%
259,455
+55.2%
0.00%0.0%
Q4 2021$3,575,000
+18.7%
167,126
+2.6%
0.00%
Q3 2021$3,011,000
-58.6%
162,923
-52.0%
0.00%
-100.0%
Q2 2021$7,265,000
+0.9%
339,341
-9.1%
0.00%0.0%
Q1 2021$7,201,000373,1980.00%
Other shareholders
ORTHO CLINICAL DIAGNOSTICS H shareholders Q1 2022
NameSharesValueWeighting ↓
Carlyle Group Inc. 143,406,000$3,070,322,00020.78%
SECTORAL ASSET MANAGEMENT INC 1,286,750$27,549,0002.23%
SHAPIRO CAPITAL MANAGEMENT LLC 5,566,581$119,180,0002.07%
Eversept Partners, LP 1,394,284$29,851,6201.99%
CRAMER ROSENTHAL MCGLYNN LLC 1,683,200$36,037,0001.16%
ARMISTICE CAPITAL, LLC 1,672,000$35,798,0000.64%
Alyeska Investment Group, L.P. 2,436,189$52,159,0000.60%
Ghisallo Capital Management LLC 426,864$9,139,0000.35%
BRANT POINT INVESTMENT MANAGEMENT LLC 155,000$3,319,0000.31%
Polar Asset Management Partners Inc. 1,275,196$27,302,0000.28%
View complete list of ORTHO CLINICAL DIAGNOSTICS H shareholders